A tool for estimating blood pressure on the left side of the heart is unable to predict the long-term survival…
Articles by Patricia Inácio, PhD
Using a multi-category index to assess pulmonary hypertension patients’ response to Adempas (riociguat) can help doctors predict their survival, a…
Echocardiograms can identify infants at risk of developing pulmonary hypertension, especially babies who are underweight, a German study reports. Early…
A study in mice offers insight into why women are more susceptible to developing pulmonary hypertension than men. It suggests…
Preclinical work supports the potential of sotatercept to be a first-in-class disease-modifying therapy for pulmonary arterial hypertension (PAH) and to moving…
A compound that scientists have been examining as a cancer therapy reduced blood pressure in pulmonary hypertension patients’ lungs, according…
Professor David Kiely, MD, and his team at Sheffield Teaching Hospitals NHS Foundation Trust in the United Kingdom, received…
Beta blockers, the cornerstone therapy for left-side heart failure, can improve pulmonary arterial hypertension, a small study indicates. The results…
African-Americans with pulmonary hypertension and without health insurance have a two-fold increased risk of dying of this disease compared to…
Adcirca (tadalafil) exerts a variety of positive effects that may explain why the therapy improves idiopathic pulmonary arterial hypertension…
Bellerophon Therapeutics has updated clinical trials testing its investigative INOpulse system for several forms of pulmonary hypertension (PH). The update is…
The Phase 4 multicenter, observational PaTTerN registry evaluating the use of Inomax (nitric oxide) in newborns with pulmonary hypertension (PH) has enrolled its first…